22 Stock and 78 ETF Arrowhead Pharmaceuticals (ARWR) alternatives
The most close Arrowhead Pharmaceuticals (ARWR) alternative is company YD Bio (YDES). The correlation is 0.834.
Stocks that highly correlated with ARWR
| Symbol | Name | Market cap | Sector | Industry | Correlation |
|---|---|---|---|---|---|
| YDES | YD Bio Ltd | $161M | Healthcare | Biotechnology | 0.83 |
| THH | TryHard Holdings Ltd | $12M | Industrials | Specialty Business Services | 0.74 |
| CAMP | CAMP4 Therapeutics Corp | $219M | Healthcare | Biotechnology | 0.71 |
| ADAMG | Adamas Trust Inc | $2.26B | N/A | N/A | 0.70 |
| KYTX | Kyverna Therapeutics Inc | $471M | Healthcare | Biotechnology | 0.67 |
| PLT | N/A | $508M | N/A | N/A | 0.67 |
| RAPP | Rapport Therapeutics Inc | $1.91B | Healthcare | Biotechnology | 0.66 |
| YXT | Yxt.Com Group Holding Ltd | $21M | Technology | Software - Application | 0.65 |
| AAUC | Allied Gold Corporation | $2.75B | Basic Materials | Gold | 0.65 |
| FBGL | FBS Global Ltd | $8.16M | Industrials | Engineering & Construction | 0.65 |
| BON | Bon Natural Life Ltd - Class A | $4.72M | Basic Materials | Specialty Chemicals | 0.64 |
| HERZ | Herzfeld Credit Income Fund Inc Com | $230M | Financial Services | Asset Management | 0.64 |
| SION | Sionna Therapeutics Inc | $2B | Healthcare | Biotechnology | 0.64 |
| CBNA | Chain Bridge Bancorp Inc - Class A | $275M | Financial Services | Banks - Regional | 0.63 |
| CV | CapsoVision Inc | $315M | Healthcare | Medical Devices | 0.63 |
| FTRE | Fortrea Holdings Inc | $1.69B | Healthcare | Biotechnology | 0.62 |
| LUD | Luda Technology Group Ltd | $98M | Basic Materials | Steel | 0.61 |
| SEPN | Septerna Inc | $1.53B | Healthcare | Biotechnology | 0.61 |
| CBLL | Ceribell Inc | $734M | Healthcare | Medical Devices | 0.60 |
| DUO | Fangdd Network Group Ltd - Class A | $30M | Real Estate | Real Estate Services | 0.60 |
| MAZE | Maze Therapeutics Inc | $1.46B | Healthcare | Biotechnology | 0.60 |
| BODI | The Beachbody Company Inc Class A | $79M | Communication Services | Internet Content & Information | 0.60 |